日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project

利用测序质量控制 2 (SEQC2) 项目中的单个细胞系测序数据,通过人工审核扩展基准插入缺失 (indel) 数据集。

Binsheng Gong ,Dan Li ,Yifan Zhang ,Rebecca Kusko ,Samir Lababidi ,Zehui Cao ,Mingyang Chen ,Ning Chen ,Qiaochu Chen ,Qingwang Chen ,Jiacheng Dai ,Qiang Gan ,Yuechen Gao ,Mingkun Guo ,Gunjan Hariani ,Yujie He ,Wanwan Hou ,He Jiang ,Garima Kushwaha ,Jian-Liang Li ,Jianying Li ,Yulan Li ,Liang-Chun Liu ,Ruimei Liu ,Shiming Liu ,Edwin Meriaux ,Mengqing Mo ,Mathew Moore ,Tyler J Moss ,Quanne Niu ,Ananddeep Patel ,Luyao Ren ,Nedda F Saremi ,Erfei Shang ,Jun Shang ,Ping Song ,Siqi Sun ,Brent J Urban ,Danke Wang ,Shangzi Wang ,Zhining Wen ,Xiangyi Xiong ,Jingcheng Yang ,Lihui Yin ,Chao Zhang ,Ruolan Zhang ,Ambica Bhandari ,Wanshi Cai ,Agda Karina Eterovic ,Dalila B Megherbi ,Tieliu Shi ,Chen Suo ,Ying Yu ,Yuanting Zheng ,Natalia Novoradovskaya ,Renee L Sears ,Leming Shi ,Wendell Jones ,Weida Tong ,Joshua Xu

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflow

使用 DEPArray™-HER2-FISH 工作流程在最初为 HER2 阴性的乳腺癌中检测出单个 HER2 阳性肿瘤细胞

Lisa Grüntkemeier, Aditi Khurana, Farideh Zamaniyan Bischoff, Oliver Hoffmann, Rainer Kimmig, Mathew Moore, Philip Cotter, Sabine Kasimir-Bauer

Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer

肾上腺允许的HSD3B1基因遗传与雌激素驱动的绝经后乳腺癌风险

Kruse, Megan L; Patel, Mona; McManus, Jeffrey; Chung, Yoon-Mi; Li, Xiuxiu; Wei, Wei; Bazeley, Peter S; Nakamura, Fumihiko; Hardaway, Aimalie; Downs, Erinn; Chandarlapaty, Sarat; Thomas, Mathew; Moore, Halle Cf; Budd, George T; Tang, W H Wilson; Hazen, Stanley L; Bernstein, Aaron; Nik-Zainal, Serena; Abraham, Jame; Sharifi, Nima